Akorn, INC.
pharmaceutical manufacturing
Based in IL
🤖
AI Overview
With $20K in lobbying spend across 4 quarterly filings, Akorn, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2023.
$20K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $10K |
| 2023 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Akorn, INC. disclosed contacting in their lobbying filings.
HOUSE OF REPRESENTATIVESSENATETreasury, Dept ofWhite House Office
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation
CARES Act Section 2305(B) refundable credit
CARES Act Section 2305(B) refundable credit.
Related Analysis
Related Investigations
Similar Clients
Health Care Service Corporation, a Mutual Legal Reserve Company (Hcsc)
$52.8M total spend
Horizon Therapeutics USA, INC. (FKA Horizon Pharma USA, INC.)
$33.6M total spend
Advocate Aurora Health, INC.
$16.8M total spend
International Motors, LLC (Formerly Navistar, INC)
$9.7M total spend
Bmo Bank N.a. (FKA Bmo Harris Bank N.a.)
$6.3M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.